Similarities between COVID-19 and systemic sclerosis early vasculopathy: A "viral" challenge for future research in scleroderma.

导出 OA

翻译打印收藏纠错

第一作者： Marco,Matucci-Cerinic

第一单位： Department of Experimental and Clinical Medicine, University of Florence & Division of Rheumatology AOUC, Florence, Italy; Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele Hospital, Milan, Italy. Electronic address: marco.matuccicerinic@unifi.it.

作者： Marco,Matucci-Cerinic ^[1] ; Michael,Hughes ^[2] ; Gloria,Taliani ^[3] ; Bashar,Kahaleh ^[4]

作者单位： Department of Experimental and Clinical Medicine, University of Florence & Division of Rheumatology AOUC, Florence, Italy; Unit of Immunology, Rheumatology, Allergy and Rare Diseases (UnIRAR), IRCCS San Raffaele Hospital, Milan, Italy. Electronic address: marco.matuccicerinic@unifi.it. ^[1] Department of Rheumatology, Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK. ^[2] Infectious Diseases Unit, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy. ^[3] Division of Rheumatology, Allergy and Immunology, University of Toledo Medical Center, Toledo, OH, USA. ^[4]

关键词 Autoimmunity COVID-19 Endothelial damage SarsCov2 Systemic sclerosis

主题词自身抗体(Autoantibodies);自身免疫(Autoimmunity);人类(Humans);硬皮病, 系统性(Scleroderma, Systemic)

DOI 10.1016/j.autrev.2021.102899

PMID 34274540

发布时间 2023-11-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交